Antibodies - Import export

This SARS-CoV-2 Neutralizing antibody Rapid Test Kit (TRFIA) is only used for rapid invitro qualitative assessment of SARS-CoV-2 neutralizing antibody in human serum/plasma/whole blood(Venipuncture and Fingerstick). For professional In VitroDiagnostic Use Only.

This SARSCoV2 Neutralizing antibody Rapid Test Kit is only used for rapid in vitro qualitative assessment of SARSCoV2 neutralizing antibody in human serum/plasma/wholeblood(Venipuncture and Fingerstick).For professional In Vitro Diagnostic Use Only.

Sars-Cov-2 Neutralization Antibody Rapid Test – Product code: SC-1569-20 The SARS-CoV-2 Neutralizing Antibody Rapid Test Cassette (Whole Blood/Serum/Plasma) is a rapid immunochromatographic test designed for the qualitative detection of neutralizing antibodies against SARS-CoV-2 that block the interaction between the domain that binds the viral spike glycoprotein receptor (RBD) and cell surface receptor ACE2 in human serum, plasma or whole blood. It is intended to be used as an aid in the identification of individuals with an adaptive immune response to SARS-CoV-2. This test should not be used to diagnose acute SARS-CoV-2 infection. The results indicate the detection of neutralizing SARS-CoV-2 antibodies. Positive results indicate the presence of neutralizing SARS-CoV-2 antibodies. The new coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease.

FIV Antibody + FeLV Antigen Combo (Whole Blood/Serum/Plasma) is a combined rapid cassette test, capable of separately diagnosing the presence of Feline Immunodeficiency Antibody and Feline Leukemia Virus Antigen in Feline Whole Blood, serum or plasma. FIV Antibody + FeLV Antigen Combo is a lateral flow immunochromatographic rapid cassette test using the direct (or Sandwich) method. The device has two test windows. Each test window has an invisible T (test) zone and C (control) zone. When the sample is applied to the wells (S) on the cassette, the liquid flows sideways on the surface of the test strip. If there is a sufficient amount of Feline immunodeficiency antibody or Feline leukemia virus antigen in the sample, a visible T line will be displayed in the corresponding test window. Line C should always appear after applying a sample, thus indicating that the result is valid.

HRP-conjugated secondary antibodies for chemiluminescent immunodetection. Nepenthe’s high-quality HRP conjugated secondary antibodies offer highsensitivity and performance for immunoblotting and ELISA applications.

AbC-19™ is a COVID-19 (SARS-CoV-2) neutralising antibody lateral flow test and produces results in 20 minutes from a small blood sample. This flexible, easy solution confirms the presence of IgG neutralising antibodies following COVID-19 infection or vaccination: an important factor in interpreting a person’s immunity status. This reliable and accurate (Sensitivity: 98.03%, Specificity: 99.56%) test can be used by trained professionals or trained lay users. The AbC-19™ testing solution is a powerful tool for limiting risks and helping governments, individuals and businesses make more informed decisions about COVID safety and vaccine programmes. An antibody certificate smartphone app is available upon request.